L'Oréal


Luxury skincare crowding limits line of sight

17/02/26 -"L’Oréal delivered FY25 results broadly in line with the top-line but ahead on margins. Strong execution in Dermatological Beauty, Professional Products and emerging markets partly offset ..."

Pages
51
Language
English
Published on
17/02/26
You may also be interested by these reports :
18/02/26
Puig delivered a stronger-than-expected Q4 25, lifting FY25 results above expectations on the back of exceptional makeup growth and better resilience ...

17/02/26
L’Oréal delivered FY25 results broadly in line with the top-line but ahead on margins. Strong execution in Dermatological Beauty, Professional ...

12/02/26
The past few years have been tough for Holmen (ADD; Sweden). To be precise, sentiment for the Swedish firm has been in a downward spiral since ...

12/02/26
Unilever reported FY 25 results, slightly below market expectations at the top line, with a 3.5% organic growth compared to the anticipated 3.7%. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO